Inventor

LEVANON AVIGDOR

IL27 patents

⚠️ This page may combine multiple inventors who share the name “LEVANON AVIGDOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEVANON AVIGDOR

BIO TECHNOLOGY GENERAL CORP

Fibrin binding domain polypeptides and uses and methods of producing same

Fibrin binding domain polypeptides and uses and methods of producing same

Polypeptide having factor Xa inhibitory activity

Analogs of hGH having antagonistic activity, and uses thereof

Fibrin binding domain polypeptide and method of producing

Method for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cell

Method for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cell

Plasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methods

Fibrin binding domain polypeptides and uses and methods of producing same

DNA encoding novel polypeptide having Factor Xa inhibitory activity

Fibrin binding domain polypeptides and uses and methods of producing same

Bacterial expression of porcine growth hormone

Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods

Bacterial expression of superoxide dismutase

Fibrin binding domain polypeptides and uses and methods of producing same

Polypeptide having factor Xa inhibitory method of reducing blood coagulation with a novel polypeptide having factor Xa inhibitory activity

Polypeptide having Factor Xa inhibitory activity

Expression vectors containing λPL promoter and T1 T2 rRNA termination sequence plasmids containing the vectors hosts containing the plasmids and related methods

Plasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methods

Expressions vectors containing Lambda PL promoter and T1 T2 RNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and relatedmethods

Plasmids for the production of human Cu-Zn superoxide dismutase, bacterial hosts containing the plasmids and methods for production and recovery of such superoxide dismutase

Production of recombinant factor Xa inhibitor of leech Hirudo medicinalis

Expression vectors containing lambdapl promoter and T1 T2 rRNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and related methods

Expression vectors containing lambdapl promoter, T1 T2 RRNA termination sequence, and origin of replication derived from a constitutive high copy number plasmid, and hosts containing the plasmids

Expression vectors containing λPL promoter, T1 T2 rRNA termination sequence and origin of replication derived from a constitutive high copy number plasmid hosts and related methods

SAVIENT PHARMACEUTICALS INC

Fibrin binding domain polypeptides and uses and methods of producing same

BIO TECHNOLOGY GENERAL ISRAEL

Specific human antibodies for selective cancer therapy